The Latin America, Middle East and Africa Automated Cell Counting Market would witness market growth of 14.9% CAGR during the forecast period (2023-2030).
Autonomous cell counters and analysers integrating numerous analytical modalities are experiencing increased market demand. By integrating functionalities such as high-content imaging, cell enumeration, viability testing, and flow cytometry, scientists can extract a greater quantity of data from samples within a single assay. Instruments with multiple techniques increase laboratory output and decrease the instrument's footprint. Miniaturized cell counting systems such as microfluidic cell counters and lab-on-a-chip devices are increasing in research laboratories.
Automated cell counters incorporate smart connectivity technologies, such as USB, Wi-Fi, and Bluetooth interfaces, to facilitate data transmission, storage, and analysis seamlessly. Software platforms enable sophisticated visualization, statistical analysis, archiving, and reporting tools for enhanced data utility. In addition, competitors provide cloud-based and application-based solutions for instrument networking and remote monitoring. The inclination towards smart data systems integrated into connected instruments to optimize cell counting insights is consistent with laboratory automation and digitization processes.
With the growing age, the incidence of age-related diseases such as cancer, neurodegenerative disorders, and cardiovascular conditions increases. This drives the need for accurate cell counting in research, diagnosis, and treatment. Older individuals often have chronic conditions requiring ongoing monitoring and treatment, leading to a higher demand for biologics and cell-based therapies, thus increasing the need for cell counting technology. Consequently, the expanded geriatric demographic in the region is catalysing the development of the market.
The Brazil market dominated the LAMEA Automated Cell Counting Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $160.3 million by 2030. The Argentina market is showcasing a CAGR of 15.5% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 14.5% during (2023 - 2030).
Based on Product, the market is segmented into Consumables Accessories, and Instruments (Image-based Cell Counters, Flow Cytometers, Electrical Impendence Coulter Counters). Based on Application, the market is segmented into Cell Line development, Blood Analysis, Stem Cell Research, and Others. Based on End-use, the market is segmented into Pharmaceutical Biotechnology Companies, Hospitals Diagnostic laboratories, Research Academic Institutes, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Shanghai Ruiyu Biotechnology Co., Ltd. (Alit Biotech (Shanghai) Co., Ltd.), Thermo Fisher Scientific, Inc., Bio-Rad laboratories, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Olympus Corporation, Merck KGaA, Abbott Laboratories, Sysmex Corporation, and Agilent Technologies, Inc.
Autonomous cell counters and analysers integrating numerous analytical modalities are experiencing increased market demand. By integrating functionalities such as high-content imaging, cell enumeration, viability testing, and flow cytometry, scientists can extract a greater quantity of data from samples within a single assay. Instruments with multiple techniques increase laboratory output and decrease the instrument's footprint. Miniaturized cell counting systems such as microfluidic cell counters and lab-on-a-chip devices are increasing in research laboratories.
Automated cell counters incorporate smart connectivity technologies, such as USB, Wi-Fi, and Bluetooth interfaces, to facilitate data transmission, storage, and analysis seamlessly. Software platforms enable sophisticated visualization, statistical analysis, archiving, and reporting tools for enhanced data utility. In addition, competitors provide cloud-based and application-based solutions for instrument networking and remote monitoring. The inclination towards smart data systems integrated into connected instruments to optimize cell counting insights is consistent with laboratory automation and digitization processes.
With the growing age, the incidence of age-related diseases such as cancer, neurodegenerative disorders, and cardiovascular conditions increases. This drives the need for accurate cell counting in research, diagnosis, and treatment. Older individuals often have chronic conditions requiring ongoing monitoring and treatment, leading to a higher demand for biologics and cell-based therapies, thus increasing the need for cell counting technology. Consequently, the expanded geriatric demographic in the region is catalysing the development of the market.
The Brazil market dominated the LAMEA Automated Cell Counting Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $160.3 million by 2030. The Argentina market is showcasing a CAGR of 15.5% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 14.5% during (2023 - 2030).
Based on Product, the market is segmented into Consumables Accessories, and Instruments (Image-based Cell Counters, Flow Cytometers, Electrical Impendence Coulter Counters). Based on Application, the market is segmented into Cell Line development, Blood Analysis, Stem Cell Research, and Others. Based on End-use, the market is segmented into Pharmaceutical Biotechnology Companies, Hospitals Diagnostic laboratories, Research Academic Institutes, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Shanghai Ruiyu Biotechnology Co., Ltd. (Alit Biotech (Shanghai) Co., Ltd.), Thermo Fisher Scientific, Inc., Bio-Rad laboratories, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Olympus Corporation, Merck KGaA, Abbott Laboratories, Sysmex Corporation, and Agilent Technologies, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Consumables Accessories
- Instruments
- Image-based Cell Counters
- Flow Cytometers
- Electrical Impendence Coulter Counters
By Application
- Cell Line development
- Blood Analysis
- Stem Cell Research
- Others
By End-use
- Pharmaceutical Biotechnology Companies
- Hospitals Diagnostic laboratories
- Research Academic Institutes
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Shanghai Ruiyu Biotechnology Co., Ltd. (Alit Biotech (Shanghai) Co., Ltd.)
- Thermo Fisher Scientific, Inc.
- Bio-Rad laboratories, Inc.
- F.Hoffmann-La Roche Ltd.
- Danaher Corporation
- Olympus Corporation
- Merck KGaA
- Abbott Laboratories
- Sysmex Corporation
- Agilent Technologies, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. LAMEA Automated Cell Counting Market by Product
Chapter 6. LAMEA Automated Cell Counting Market by Application
Chapter 7. LAMEA Automated Cell Counting Market by End-use
Chapter 8. LAMEA Automated Cell Counting Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Shanghai Ruiyu Biotechnology Co., Ltd. (Alit Biotech (Shanghai) Co., Ltd.)
- Thermo Fisher Scientific, Inc.
- Bio-Rad laboratories, Inc.
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Olympus Corporation
- Merck KGaA
- Abbott Laboratories
- Sysmex Corporation
- Agilent Technologies, Inc.
Methodology
LOADING...
